In a large randomized trial, treating patients with acute hypoxemic respiratory failure with high-flow oxygen didn't improve survival compared with standard oxygen. However, high-flow oxygen did ...

SAN FRANCISCO -- Starting high-flow oxygen right away for young children with acute hypoxemic respiratory failure didn't help them leave the hospital sooner than standard oxygen therapy, the PARIS-2 ...

IRVINE, Calif.--(BUSINESS WIRE)--Telesair, Inc., a technology leader in the respiratory industry, announced today that it has received FDA clearance to market its Bonhawa High Flow Oxygen Therapy ...